Healthcare Unfiltered Express

Arguably, the development and approval of Menin Inhibitors in AML are one of the most important advances in this disease in the past 1-2 years. Dr. Uma Borate joins Healthcare Unfiltered EXPRESS and shares with us everything we must know about this class of drugs: how they are used, their toxicities, and what the future of AML management may look like now that we have Menin inhibitors. Check it out, subscribe, and review.

Dr. Marc Braunstein from NYU Langone joins the Healthcare Unfiltered EXPRESS to describe the recently published BRUIN-313 trial in frontline CLL and its potential impact on the treatment landscape for this disease. Check it out, subscribe, share, and join the conversation.

Dr. Ishwaria Subbiah joined the Healthcare Unfiltered EXPRESS to discuss burnout, a problem physicians and many other healthcare providers face. She offers that AI and technology may bring solutions to reduce this problem and improve satisfaction. Check it out, subscribe, review, share, and join the conversation.

Dr. Sara Tolaney of the Dana-Farber Cancer Institute joined the show to share her insights on the ASCENT-04 trial recently published in NEJM. This is an RCT in triple-negative breast cancer. Sara led this study and as the lead author, she puts its results in context - this is a must-listen episode. Please share, review, and subscribe.

Dr. Ajay Nooka of Emory University and the Winship Cancer Institute joins Healthcare Unfiltered EXPRESS to tell us about CELMoDs in multiple myeloma. What are these agents? How do they work? How do they help patients with myeloma? And what does the future of this disease look like now that we may have CELMoDs for this disease? A must listen, and please share your comments.

Dr. Kasi from the City of Hope joins the Healthcare Unfiltered EXPRESS for a chat on what intrigued him at the last ASCO GI meeting that took place a few weeks ago. What mattered and did any standards of care changed?

Take a listen, share, subscribe, review, and join the conversation.

Dr. Dan Olson of the University of Chicago joins the Healthcare Unfiltered EXPRESS to discuss the current state of TILs in cancer therapy, specifically in melanoma. Dr. Olson describes the technology, how to deliver, how to mitigate side effects, and offers valuable insights on future directions. A mist listen - please share, review, and subscribe.

Dr. Erika Hamilton from the SCRI joined the show to give timely and important updates on how treating breast cancer may be changing in view of trial data presented at the 2025 December SABCS meeting that just concluded. A must listen episode to stay up to date with new emerging data and therapies in breast cancer. Please share and subscribe.

Dr. Julio Chavez of the Mayo Clinic joins the Healthcare Unfiltered EXPRESS to explain data on this class of drugs, their mechanism of action, and where they fit in the treatment armamentarium of various lymphomas. The best way to stay up to date is to subscribe and share.

Dr. Vincent Rajkumar of the Mayo Clinic visits the Healthcare Unfiltered EXPRESS to review published data on what constitutes myeloma on the molecular and genomic level. Turns out that some patients that we thought do not have myeloma, they indeed have the disease. A must listen and a provocative episode. Please rate, share, and subscribe

I am joined by Dr. Erica Conroy, CEO of Primm.co, and Dr. Matt Kurian, a breast medical oncologist. They both share the importance of curbside consults between oncologists at the point of care. Erica leads an innovative company that allows exchange of ideas, opinions, and aid to healthcare professionals to navigate the complexity of medical oncology by seeking consults form peers and KOLs exactly when they need it most. Matt has used the platform and is now an expert in helping others.

Check out the podcast and try Primum for yourself https://primum.co/?utm_source...

Dr. Mazyar Shadman joined Healthcare Unfiltered EXPRESS to share his insights on data-driven approaches to treating CLL in the front-line setting. Timely podcast as we approach the annual ASH 2025 meeting. Check it out, subscribe, and join the conversation.

Dr. Matt Lunning from the University of Nebraska simplifies how best we approach these aggressive diverse collections of lymphomas. Concise and straight to the point; check it out, subscribe, and join the conversation.

Dr. Matthew Kurian joins Healthcare Unfiltered EXPRESS to share his observations and insights on new emerging targets in breast cancer and how these targets are driving treatment selection across all disease stages. Please subscribe, review, and join the conversation.

Dr. Karima Oualla joins the show to share how she brings research studies and scientific progress to clinical practice in Morocco. Despite limited resources, Dr. Oualla has pioneered research and cutting edge clinical care in her home country. Please subscribe, share, and join the conversation. 

Should we treat cancers regardless of where they had originated from? Dr. Vivek Subbiah, world-renowned oncologist and researcher, joined Healthcare Unfiltered EXPRESS to advocate that this is the way of the future. A must listen episode looking into the future of cancer therapeutics. Please subscribe, share, and join the conversation.

Dr. Anwaar Saeed joined Healthcare Unfiltered EXPRESS to discuss her recent paper published in The Lancet that addressed treating metastatic refractory colorectal cancers. Please share your thoughts and subscribe.

Dr. Karine Tawagi joins the show to detail prostate cancer data from ESMO 2025 that carries the most important clinical implications. What trial data mattered the most? Take a listen and join the conversation.

From Madrid, Dr. Enrique Grande joins Healthcare Unfiltered EXPRESS to share his thoughts and insights on data pertaining to renal cancer from the latest ESMO 2025 meeting. A 13-minutes that is worth your time. Please subscribe and join the conversation.

Dr. Bishoy Faltas, a world-renowned researcher with a focus on bladder and urothelial cancers, reflected on how the data from ESMO 2025 may shape current and future translational and bench research in these diseases. No one better than Bishoy to explain the current research landscape and what is yet to come. Check it out, and please subscribe and rate.

Dr. Petros Grivas from the Fred Hutch Cancer Center joins the show to share his timely insights on data presented at the ESMO 2025 meeting pertaining to urothelial cancers. Petros focuses on data that is practice changing or practice informing. Check it out, and join the conversation.

Dr. Sapna Patel, a world-renowned expert in melanoma from the University of Colorado, joins Healthcare Unfiltered EXPRESS to share new data and insights from the recently completed ESMO 2025 meeting in Berlin.
Check it out, subscribe, share, and review.

Dr. Sarah Sammons of Dana-Farber Cancer Institute visits Healthcare Unfiltered EXPRESS to share timely and important insights and data from the ESMO 2025 congress that was recently concluded. Get up to speed with all data that has clinical implications in breast cancer and was presented at the meeting.

Dr. Ari Rosenberg from the University of Chicago joins the show to share the most clinically relevant updates from the annual ESMO 2025 meeting that just concluded in Berlin. Check it out, and join the conversation.

Learn from Dr. Tim Brown what is new in adjuvant therapy for colon cancer.

The Annual AVBCC meeting takes place in NYC every year - if you did not attend, fear not as Dr. Doug Flora provides viewers and listeners of #HealthcareUnfiltered EXPRESS with behind the scene look at what happened at the meeting, its goals, take home points, and what is next. Check it out, and join the conversation.

In less than 10 minutes, Dr. Pal simplifies to everyone how best to manage papillary kidney cancer.

Learn about the AI powered Digital Twins and how they can help in unlocking the potential of expediting clinical trials and advancing clinical research.

Dr. Nowakowski was at the ODAC meeting that denied Blenrep's indication, and he casted his vote. Learn from him what happened at the actual ODAC meeting, and what are the implication of the ODAC decision on this myeloma therapy.

Dr. Ray Rao, CEO of Ankr Health, shares his insights on how this government shutdown is affecting patients and families who are in urgent need for telehealth and telemedicine. Listen to this timely podcast and let's try to help all patients where we can.

Dr. Zeidan shares his thoughts on the recent news that the VERONA trial in high-risk MDS was negative.

Dr. Soror, a gradating fellow who just started her first year as an attending, shares with all what she wished she had known when she started her fellowship. Every Heme/Onc fellow must listen to this one.

Dr. Yelena Janjigian of Memorial Sloan Kettering Cancer Center joins the Healthcare Unfiltered Express to provide a timely and concise overview on how best to treat upper GI Cancers. So much data on IO in upper GI cancers and more to come at ESMO 2025; take a listen to this timely podcast, subscribe, share, and join the conversation.

Lots of changes in managing advanced Hodgkin lymphoma especially with recent SWOG1826 data. Dr. Ann LaCasce provides an overview with excellent clinical pearls on how to approach this curabe malignancy.

Dr. Rana McKay visits the Healthcare Unfiltered EXPRESS to share her insights of how best to treat clear cell renal cell carcinoma - perfect listen ahead of the ESMO 2025 meeting happening this week as more GU oncology data emerges.

Please subscribe, share, and join the conversation.

Dr. Halmos from Montefiore in New York shares his views on the most impactful practice changing or informing data for lung cancer from the ASCO 2025 meeting.

Dr. Andrea Apolo from the NCI and world-renowned GU oncologist joins the Healthcare Unfiltered EXPRESS to share her insights on how best to manage urothelial cancers in view of so much new data and in anticipation of the ESMO-2025 data expected soon.

Dr. Rajkumar from the Mayo Clinic explains why many have been disappointed by the ODAC decision to recommend not approving Benrep for relapsed/refractory multiple myeloma. Thought provoking. This was taped live while we broadcasted on Twitter Spaces on 7/22/2025.

Dr. Saurabh Dahiya from Stanford University explains the recent changes in the FDA recommendations regarding the monitoring program previously mandated for centers delivering CAR-T therapies, and why this decision was celebrated by patients and their physicians.

Dr. Jonathan Chen from Stanford visits the Healthcare Unfiltered Express to describe how AI can or maybe cannot aid in complex decision making. This is a must listen episode; get a glimpse of how AI might change how we care for patients.